Bp Wealth Management »

Summit Therapeutics shares owned by Bp Wealth Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Bp Wealth Management from 13F filings

Historical chart of Bp Wealth Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Bp Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Bp Wealth Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $236k 12k 19.29
2024-12-31 $274k 15k 17.85
2024-06-30 $134k 17k 7.80

More positions owned by Bp Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
iShares Russell Top 200 Growth Etf (IWY)
Broadcom (AVGO)
Amazon (AMZN)
iShares Russell Top 200 Value Etf (IWX)
Ishares Trust Core Us Aggbd Et Etf (AGG)
NVIDIA Corporation (NVDA)
Ishares Trust Core Msci Eafe E Etf (IEFA)
Ishares Russell Mid-cap Value Etf (IWS)
JPMorgan Chase & Co. (JPM)
Alphabet Inc Class A cs (GOOGL)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p500 Etf Trust Trust Un Etf (SPY)
Ishares Tr Rus Md Cp Gr Etf Etf (IWP)

View all positions for Bp Wealth Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics